Do Peroxisome Proliferating Compounds Pose a Hepatocarcinogenic Hazard to Humans?

Author： Cattley R.C.   deLuca J.   Elcombe C.   Fenner-Crisp P.   Lake B.G.   Marsman D.S.   Pastoor T.A.   Popp J.A.   Robinson D.E.   Schwetz B.   Tugwood J.   Wahli W.  

Publisher： Academic Press

ISSN： 0273-2300

Source： Regulatory Toxicology and Pharmacology, Vol.27, Iss.1, 1998-02, pp. : 47-60

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Rational Targeting of Peroxisome Proliferating Activated Receptor Subtypes

By  

Current Medicinal Chemistry, Vol. 18, Iss. 36, 2011-12 ,pp. : 5598-5623

Bentham Science Publishers

Access to resources Recommend Favorite

Genotoxic hazard of radiopharmaceuticals in humans: chemical and radiation aspects coupled to microdosing

By Lundqvist H.   Antoni G.   Långström B.  

European Journal of Clinical Pharmacology, Vol. 63, Iss. 7, 2007-07 ,pp. : 641-645

Springer Publishing Company

Access to resources Recommend Favorite

PARAOXONASE AND ACETYLCHOLINESTERASE ACTIVITIES IN HUMANS EXPOSED TO ORGANOPHOSPHOROUS COMPOUNDS

By Akgur S. A.   Ozturk P.   Sozmen E. Y.   Delen Y.   Tanyalcin T.   Ege B.  

Journal of Toxicology and Environmental Health, Vol. 58, Iss. 8, 1999-12 ,pp. : 469-474

Taylor & Francis Ltd

Access to resources Recommend Favorite

Do Biological Medicinal Products Pose a Risk to the Environment?: A Current View on Ecopharmacovigilance

By Kühler Thomas C.   Andersson Mikael   Carlin Gunnar   Johnsson Ann   Åkerblom Lennart  

Drug Safety, Vol. 32, Iss. 11, 2009-11 ,pp. : 995-1000

Adis International

Access to resources Recommend Favorite

Do peroxisome proliferation receptor-γ antagonists have clinical potential as combined antiobesity and antidiabetic drugs?

By Doggrell Sheila  

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 4, 2003-04 ,pp. : 713-716

Informa Healthcare

Access to resources Recommend Favorite